Danielle Antalffy Analyst PerformanceAnalyst at UBS GroupDanielle Antalffy is a stock analyst at UBS Group in the healthcare sector, covering 22 publicly traded companies. Over the past year, Danielle Antalffy has issued 51 stock ratings, including buy, hold, and sell recommendations. While full access to Danielle Antalffy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Danielle Antalffy's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings92 Last 11 YearsBuy Recommendations56.98% 49 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution86RatingsDistribution of strong buy, buy, hold, and sell ratings by Danielle Antalffy.RatingPercentageCount Strong Buy0.0%0 ratings Buy57.0%49 ratings Hold38.4%33 ratings Sell4.7%4 ratingsOut of 86 total stock ratings issued by Danielle Antalffy at UBS Group, the majority (57.0%) have been Buy recommendations, followed by 38.4% Hold and 4.7% Sell.Best & Worst CallsBest Call000.0%GKOSJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BSXJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE50.0% of companies on NYSE11 companiesNASDAQ50.0% of companies on NASDAQ11 companiesDanielle Antalffy, an analyst at UBS Group, currently covers 22 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare22 companies100.0%Danielle Antalffy of UBS Group specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES21 companies95.5%PHARMACEUTICALS1 company4.5% About Danielle AntalffyDanielle Antalffy currently works at UBS Securities LLC, as Analyst from 2022. Ms. Antalffy also formerly worked at Leerink Partners LLC, as Managing Director from 2008 to 2022, Bear, Stearns & Co., Inc., as Research Analyst from 2006 to 2008, and Janney Montgomery Scott LLC, as Research Associate. Ms. Antalffy received her undergraduate degree in 2002 from the University of Pennsylvania. Danielle Antalffy's Ratings History at UBS Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBSXBoston Scientific7/28/2026Reiterated Rating$46.82$74.00Buy$0.0000.00% ROIGKOSGlaukos7/28/2026Initiated Coverage$152.07$150.00Neutral$0.0000.00% ROIBSXBoston Scientific7/28/2026Reiterated Rating$45.56$74.00Buy$0.0000.00% ROIENOVEnovis7/28/2026Reiterated Rating$28.26$51.00Buy$0.0000.00% ROISYKStryker7/28/2026Initiated Coverage$337.31$400.00Buy$0.0000.00% ROIPRCTPROCEPT BioRobotics7/28/2026Downgrade$17.69$20.00Neutral$0.0000.00% ROIENOVEnovis7/28/2026Reiterated Rating$30.18$51.00Buy$0.0000.00% ROIBSXBoston Scientific3/17/2026Lower Price Target$71.67$105.00Buy$0.0000.00% ROISYKStryker3/17/2026Lower Price Target$352.47$380.00Neutral$0.0000.00% ROISGHTSight Sciences3/6/2026Lower Price Target$3.67$11.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RXSTRxSight2/26/2026Boost Price Target$7.96$9.00Neutral$0.0000.00% ROIISRGIntuitive Surgical2/24/2026Set Price Target$490.91$570.00Neutral$0.0000.00% ROISYKStryker2/24/2026Boost Price Target$384.82$400.00Neutral$0.0000.00% ROITNDMTandem Diabetes Care2/20/2026Reiterated Rating$18.52$22.00Neutral$0.0000.00% ROIATRCAtriCure2/18/2026Lower Price Target$31.32$55.00Buy$0.0000.00% ROIINSPInspire Medical Systems2/13/2026Set Price Target$62.81$67.00$0.0000.00% ROIZBHZimmer Biomet2/11/2026Reiterated Rating$92.85$89.00Sell$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$120.00Buy$0.0000.00% ROIMDTMedtronic2/4/2026Reiterated Rating$103.63$104.00Neutral$0.0000.00% ROIEWEdwards Lifesciences2/4/2026Reiterated Rating$81.79$94.00Neutral$0.0000.00% ROIZBHZimmer Biomet1/28/2026Lower Price Target$85.71$86.00Sell$0.0000.00% ROIINSPInspire Medical Systems1/22/2026Set Price Target$80.81$96.00$0.0000.00% ROIISRGIntuitive Surgical1/15/2026Reiterated Rating$536.36Neutral$0.0000.00% ROIRXSTRxSight1/12/2026Reiterated Rating$9.80Neutral$0.0000.00% ROIEWEdwards Lifesciences1/12/2026Reiterated Rating$83.66$95.00Neutral$0.0000.00% ROIENOVEnovis1/5/2026Reiterated Rating$27.51$50.00Buy$0.0000.00% ROIJNJJohnson & Johnson1/5/2026Reiterated Rating$202.40Buy$0.0000.00% ROIGKOSGlaukos12/23/2025Boost Price Target$116.83$145.00Buy$0.0000.00% ROIINSPInspire Medical Systems12/23/2025Boost Price Target$97.70$91.00Neutral$0.0000.00% ROISGHTSight Sciences12/23/2025Boost Price Target$8.44$12.00Buy$0.0000.00% ROIPODDInsulet12/18/2025Reiterated Rating$296.75Buy$0.0000.00% ROIBSXBoston Scientific12/17/2025Reiterated Rating$94.93Buy$0.0000.00% ROIGKOSGlaukos12/17/2025Set Price Target$115.53$165.00$0.0000.00% ROIPRCTPROCEPT BioRobotics12/12/2025Initiated Coverage$35.74$62.00Buy$0.0000.00% ROIPRCTPROCEPT BioRobotics12/12/2025Initiated Coverage$36.10$62.00Buy$0.0000.00% ROIEWEdwards Lifesciences12/3/2025Reiterated Rating$84.79$92.00Neutral$0.0000.00% ROIMDTMedtronic11/19/2025Boost Price Target$100.87$102.00Neutral$0.0000.00% ROIGKOSGlaukos11/10/2025Reiterated Rating$86.68$140.00Buy$0.0000.00% ROITMCITreace Medical Concepts11/7/2025Lower Price Target$3.82$5.85Neutral$0.0000.00% ROIZBHZimmer Biomet11/6/2025Lower Price Target$87.82$88.00Sell$0.0000.00% ROIFree Stock Pick: The Company First in Line for America’s New Super Fuel (Ad)The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by President Trump to deploy a revolutionary new fuel. The first powerplant running this fuel is expected to go live before December 18, 2026. One obscure defense contractor already has a five-year head start on every competitor. The name, ticker symbol, and full story are being revealed at no cost.Click here to get the stock name, ticker, and full Project Janus details freeINMDInMode11/6/2025Lower Price Target$14.55$16.00Neutral$0.0000.00% ROIDXCMDexCom11/3/2025Lower Price Target$60.43$95.00Buy$0.0000.00% ROIBAXBaxter International10/31/2025Lower Price Target$18.79$21.00Neutral$0.0000.00% ROIISRGIntuitive Surgical10/23/2025Set Price Target$527.03$600.00Neutral$0.0000.00% ROIBSXBoston Scientific10/23/2025Boost Price Target$103.90$140.00Buy$0.0000.00% ROIJNJJohnson & Johnson10/14/2025Boost Price Target$188.17$214.00Buy$0.0000.00% ROIISRGIntuitive Surgical10/13/2025Set Price Target$429.59$529.00$0.0000.00% ROIJNJJohnson & Johnson10/3/2025Set Price Target$185.98$198.00$0.0000.00% ROIINSPInspire Medical Systems9/22/2025Set Price Target$79.86$89.00Neutral$0.0000.00% ROIINSPInspire Medical Systems9/22/2025Downgrade$78.96$89.00Neutral$0.0000.00% ROIMDTMedtronic8/20/2025Boost Price Target$93.29$95.00Neutral$0.0000.00% ROIZBHZimmer Biomet8/8/2025Boost Price Target$97.67$96.00Sell$0.0000.00% ROITMCITreace Medical Concepts8/8/2025Reiterated Rating$6.26$6.50Neutral$0.0000.00% ROIRXSTRxSight8/8/2025Lower Price Target$7.35$8.00Neutral$0.0000.00% ROIENOVEnovis8/8/2025Lower Price Target$28.91$57.00Buy$0.0000.00% ROITNDMTandem Diabetes Care8/7/2025Lower Price Target$11.27$17.00Neutral$00.0000.00% ROIINSPInspire Medical Systems8/5/2025Set Price Target$79.42$230.00Buy$00.0000.00% ROIBAXBaxter International8/4/2025Lower Price Target$22.13$24.00Neutral$00.0000.00% ROIDXCMDexCom7/31/2025Boost Price Target$89.06$106.00Buy$00.0000.00% ROIGKOSGlaukos7/31/2025Boost Price Target$94.02$134.00Buy$000.0000.00% ROIBSXBoston Scientific7/24/2025Boost Price Target$105.63$135.00Buy$00.0000.00% ROIISRGIntuitive Surgical7/23/2025Boost Price Target$501.95$585.00Neutral$000.0000.00% ROIJNJJohnson & Johnson7/17/2025Boost Price Target$163.41$190.00Buy$000.0000.00% ROITMCITreace Medical Concepts5/9/2025Lower Price Target$6.83$8.60Neutral$0.0000.00% ROIATRCAtriCure4/30/2025Lower Price Target$29.29$58.00Buy$00.0000.00% ROIINMDInMode4/29/2025Lower Price Target$14.16$16.25Neutral$00.0000.00% ROIMDTMedtronic2/19/2025Boost Price Target$86.05$95.00Neutral$00.0000.00% ROIBSXBoston Scientific2/7/2025Boost Price Target$105.15$130.00Buy$00.0000.00% ROIABTAbbott Laboratories1/23/2025Boost Price Target$117.76$148.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenBarclaysRoyal Bank Of CanadaMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupBMO Capital MarketsSanford C. BernsteinBerenberg BankBNP Paribas ExaneCompass PointPiper SandlerCanadian Imperial Bank of CommerceWeiss RatingsUBS Group Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
